Eleven years secular trend of the initiation of anti-osteoporosis medications and subsequent fractures in Taiwan: From 2008 to 2018
Background: Osteoporosis is a common metabolic bone disease that benefits from many newly developed anti-osteoporosis medications (AOMs). Reimbursement policies need to allocate medical budgets properly based on evidence-based data. This study aimed to investigate the 11-year secular trend, focusing...
Main Authors: | Tsung-Han Yang, Chen-Yu Wang, Shau-Huai Fu, Ding-Cheng Chan, Ho-Min Chen, Jou-Wei Lin, Chun-Feng Huang, Jen-Jia Yang, Chih-Hsing Wu, Jawl-Shan Hwang, Rong-Sen Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664623001924 |
Similar Items
-
Constraining in reimbursement criteria and the adherence to anti-osteoporosis medications (AOMs) in Taiwan: Urbanization makes the difference
by: Chen-Yu Wang, et al.
Published: (2023-01-01) -
Cost and effectiveness analyses of the anti-osteoporosis medication in patients with hip fracture in Taiwan: A population-based national claims database analysis
by: Chen-Yu Wang, et al.
Published: (2023-01-01) -
Analysis of the subsequent treatment of osteoporosis by transitioning from bisphosphonates to denosumab, using quantitative computed tomography: A prospective cohort study
by: Koki Tsuchiya, et al.
Published: (2021-06-01) -
Epidemiology and clinical impact of osteoporosis in Taiwan: A 12-year trend of a nationwide population-based study
by: Ming-Tsung Lee, et al.
Published: (2023-01-01) -
Impact of the Requirement of Bone Mineral Density Evidence on Utilization of Anti-osteoporosis Medications, Clinical Outcome and Medical Expenditures of Patient With Hip Fracture in Taiwan
by: Chen-Yu Wang, et al.
Published: (2022-04-01)